--- title: "U.S. Stock Market Movement Update: The biotechnology sector rebounded strongly, with Intellia rising 31.33% to lead the gains, while Cheetah fell 20%, attracting attention" type: "News" locale: "en" url: "https://longbridge.com/en/news/284172745.md" description: "In the past hour, the overall market in the US stock market has shown significant differentiation, with technology stocks and the biopharmaceutical sector performing particularly well. The strong rise of Intellia Therapeutics has attracted market attention, driving the activity of related biotech stocks. Meanwhile, Cheetah Net Supply Chain and Scinai Immunotherapeutics have experienced significant declines, indicating a rapid shift of funds between different sectors. Short-term interest seems to be concentrated on those promising technology and pharmaceutical stocks, with large fluctuations and active market sentiment. The stock with the largest movement in the past hour, Intellia Therapeutics, surged by 31.33%, becoming the market focus. The strong performance of this stock has attracted a large influx of funds, boosting short-term sentiment and driving the overall rise of the biotech sector. Strong stocks include: 1. Organon: up 16.61%, with recent market attention on its product line and noticeable fund inflow. 2. MagnaChip Semiconductor: up 16.38%, benefiting from the recovery in semiconductor demand, with short-term funds actively participating. 3. SurgePays: up 7.70%, as the company's recent financial report exceeded expectations, attracting investor interest. 4. POET Tech: up 7.62%, with optimistic market expectations regarding its technological progress driving the stock price increase" datetime: "2026-04-27T08:00:18.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284172745.md) - [en](https://longbridge.com/en/news/284172745.md) - [zh-HK](https://longbridge.com/zh-HK/news/284172745.md) --- # U.S. Stock Market Movement Update: The biotechnology sector rebounded strongly, with Intellia rising 31.33% to lead the gains, while Cheetah fell 20%, attracting attention **Market Overview of US Stocks in the Last Hour** The overall market shows a clear divergence, with technology stocks and the biopharmaceutical sector performing particularly well. The strong rise of Intellia Therap has attracted market attention, driving the activity of related biotech stocks. Meanwhile, Cheetah Net Supply Chain and Scinai Immunotherapeutics have experienced significant declines, indicating a rapid shift of funds between different sectors. Short-term enthusiasm seems to be concentrated on those promising technology and pharmaceutical stocks, with large fluctuations and active market sentiment. **Stocks with the Most Significant Movements in the Last Hour** Intellia Therap rose by 31.33%, becoming the market focus. The strong performance of this stock attracted a large influx of funds, boosting short-term sentiment and driving the overall rise of the biotech sector. **Strong Stocks** 1. Organon: Up 16.61%, recent market attention on its product line has led to significant fund inflows. 2. MagnaChip Semiconduct: Up 16.38%, benefiting from the recovery in semiconductor demand, with active short-term fund involvement. 3. SurgePays: Up 7.70%, the company's recent financial report exceeded expectations, attracting investor interest. 4. POET Tech: Up 7.62%, optimistic expectations regarding its technological progress have driven the stock price up. 5. MaxLinear: Up 6.68%, performing well under the influence of the semiconductor sector. 6. Faraday Future Intelligent Electric: Up 6.42%, the continued enthusiasm in the electric vehicle market supports the stock price rise. 7. Wing Yip Food China: Up 6.36%, the recovery in food industry demand has driven its stock price up. 8. Qualcomm: Up 5.72%, the ongoing development of 5G technology brings new growth momentum. 9. Wheeler Real Estate: Up 3.37%, signs of recovery in the real estate market have attracted investor attention. **Stocks Under Pressure** 1. Cheetah Net Supply Chain: Down 20.00%, increasing market concerns about its future prospects have led to significant fund outflows. 2. Scinai Immunotherapeutics: Down 19.17%, recent lack of positive news has resulted in insufficient investor confidence. 3. Zspace: Down 11.72%, declining market acceptance of its products has put pressure on the stock price. 4. Network 1 Tech: Down 8.16%, lacking catalysts in the short term has accelerated fund outflows. 5. XORTX Therapeutics: Down 7.59%, low market sentiment has led to a decline in stock price ### Related Stocks - [NTLA.US](https://longbridge.com/en/quote/NTLA.US.md) - [CTNT.US](https://longbridge.com/en/quote/CTNT.US.md) - [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md) - [OGN.US](https://longbridge.com/en/quote/OGN.US.md) - [MX.US](https://longbridge.com/en/quote/MX.US.md) - [ZSPC.US](https://longbridge.com/en/quote/ZSPC.US.md) - [NTIP.US](https://longbridge.com/en/quote/NTIP.US.md) - [SURG.US](https://longbridge.com/en/quote/SURG.US.md) - [POET.US](https://longbridge.com/en/quote/POET.US.md) - [XRTX.US](https://longbridge.com/en/quote/XRTX.US.md) - [MXL.US](https://longbridge.com/en/quote/MXL.US.md) - [FFAI.US](https://longbridge.com/en/quote/FFAI.US.md) - [WYHG.US](https://longbridge.com/en/quote/WYHG.US.md) - [QCOM.US](https://longbridge.com/en/quote/QCOM.US.md) - [WHLR.US](https://longbridge.com/en/quote/WHLR.US.md) ## Related News & Research - [Why Poet Technologies stock skyrocketed this week](https://longbridge.com/en/news/286681063.md) - [POET Technologies Posts Higher Q1 2026 Revenue but Swings to Net Loss as Costs Surge](https://longbridge.com/en/news/286588263.md) - [POET Stock Jumped on $500 Million Deal With Lumilens. Its Financials Have a Long Way to Go.](https://longbridge.com/en/news/286600014.md) - [POET Technologies GAAP EPS of -$0.08 misses by $0.03, revenue of $0.5M beats by $0.25M](https://longbridge.com/en/news/286510324.md) - [Poet Technologies sank today -- is the stock a buy right now?](https://longbridge.com/en/news/286625118.md)